How much is the Bispecific Antibodies For Cancer market?

The bispecific antibodies for cancer market size is estimated to grow at $$ 338 mn in 2024. Read More

What is the growth rate of the Bispecific Antibodies For Cancer market?

The growth rate of the bispecific antibodies for cancer year-over-year is 6.9%. Read More

Which region held the largest market share in the Bispecific Antibodies For Cancer market?

Asia is the region to held the largest market share with 32% growth. Read More

Who are the key players in the Bispecific Antibodies For Cancer market?

ABL Bio Inc., AFFIMED N.V., Akeso Inc., Amgen Inc., Aptevo Therapeutics Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Eli Lilly and Co., EPIMAB .... Read More

Which Segment has the largest market share in the Bispecific Antibodies For Cancer market?

Type is the segment that has the largest market share in the market. Read More

Bispecific Antibodies For Cancer Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Ireland, Canada, India, China, Hungary, Germany, Japan, UK, Brazil - Size and Forecast 2025-2029

Published: Feb 2025
Pages: 233
SKU: IRTNTR72677

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Action Mechanism
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2024

4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Bispecific Antibodies For Cancer Market 2019 - 2023
- Historic Market Size - Data Table on Global Bispecific Antibodies For Cancer Market 2019 - 2023 ($ million)

5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)

5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)

5.4 Action Mechanism segment analysis 2019 - 2023
- Historic Market Size - Action Mechanism Segment 2019 - 2023 ($ million)

5.5 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)

5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)

5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Bispecific Antibodies for Cancer Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029

7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)

8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type

8.3 CD19 or CD3 - Market size and forecast 2024-2029
- Chart on CD19 or CD3 - Market size and forecast 2024-2029 ($ million)
- Data Table on CD19 or CD3 - Market size and forecast 2024-2029 ($ million)
- Chart on CD19 or CD3 - Year-over-year growth 2024-2029 (%)
- Data Table on CD19 or CD3 - Year-over-year growth 2024-2029 (%)

8.4 CD30 or CD16A - Market size and forecast 2024-2029
- Chart on CD30 or CD16A - Market size and forecast 2024-2029 ($ million)
- Data Table on CD30 or CD16A - Market size and forecast 2024-2029 ($ million)
- Chart on CD30 or CD16A - Year-over-year growth 2024-2029 (%)
- Data Table on CD30 or CD16A - Year-over-year growth 2024-2029 (%)

8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)

9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel

9.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)

9.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)

9.5 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)

9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Action Mechanism

10.1 Market segments
- Chart on Action Mechanism - Market share 2024-2029 (%)
- Data Table on Action Mechanism - Market share 2024-2029 (%)

10.2 Comparison by Action Mechanism
- Chart on Comparison by Action Mechanism
- Data Table on Comparison by Action Mechanism

10.3 Dual antigen targeting - Market size and forecast 2024-2029
- Chart on Dual antigen targeting - Market size and forecast 2024-2029 ($ million)
- Data Table on Dual antigen targeting - Market size and forecast 2024-2029 ($ million)
- Chart on Dual antigen targeting - Year-over-year growth 2024-2029 (%)
- Data Table on Dual antigen targeting - Year-over-year growth 2024-2029 (%)

10.4 Dual-blocking antibodies - Market size and forecast 2024-2029
- Chart on Dual-blocking antibodies - Market size and forecast 2024-2029 ($ million)
- Data Table on Dual-blocking antibodies - Market size and forecast 2024-2029 ($ million)
- Chart on Dual-blocking antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Dual-blocking antibodies - Year-over-year growth 2024-2029 (%)

10.5 T-cell engagers - Market size and forecast 2024-2029
- Chart on T-cell engagers - Market size and forecast 2024-2029 ($ million)
- Data Table on T-cell engagers - Market size and forecast 2024-2029 ($ million)
- Chart on T-cell engagers - Year-over-year growth 2024-2029 (%)
- Data Table on T-cell engagers - Year-over-year growth 2024-2029 (%)

10.6 Market opportunity by Action Mechanism
- Market opportunity by Action Mechanism ($ million)
- Data Table on Market opportunity by Action Mechanism ($ million)

11 Market Segmentation by Therapeutic Area

11.1 Market segments
- Chart on Therapeutic Area - Market share 2024-2029 (%)
- Data Table on Therapeutic Area - Market share 2024-2029 (%)

11.2 Comparison by Therapeutic Area
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area

11.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)

11.4 Autoimmune diseases - Market size and forecast 2024-2029
- Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%)

11.5 Infectious diseases - Market size and forecast 2024-2029
- Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)

11.6 Neurological disorders - Market size and forecast 2024-2029
- Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
- Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)

11.7 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)

12 Customer Landscape

12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

13.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)

13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)

13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)

13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)

13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)

13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)

13.8 Ireland - Market size and forecast 2024-2029
- Chart on Ireland - Market size and forecast 2024-2029 ($ million)
- Data Table on Ireland - Market size and forecast 2024-2029 ($ million)
- Chart on Ireland - Year-over-year growth 2024-2029 (%)
- Data Table on Ireland - Year-over-year growth 2024-2029 (%)

13.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)

13.10 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)

13.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)

13.12 Hungary - Market size and forecast 2024-2029
- Chart on Hungary - Market size and forecast 2024-2029 ($ million)
- Data Table on Hungary - Market size and forecast 2024-2029 ($ million)
- Chart on Hungary - Year-over-year growth 2024-2029 (%)
- Data Table on Hungary - Year-over-year growth 2024-2029 (%)

13.13 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)

13.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)

13.15 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)

13.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)

13.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity/Restraints

14.1 Market drivers

14.2 Market challenges

14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

14.4 Market opportunities/restraints

15 Competitive Landscape

15.1 Overview

15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

15.3 Landscape disruption
- Overview on factors of disruption

15.4 Industry risks
- Impact of key risks on business

16 Competitive Analysis

16.1 Companies profiled
- Companies covered

16.2 Company ranking index
- Company ranking index

16.3 Market positioning of companies
- Matrix on companies position and classification

16.4 ABL Bio Inc.
- ABL Bio Inc. - Overview
- ABL Bio Inc. - Product / Service
- ABL Bio Inc. - Key offerings
- SWOT

16.5 AFFIMED N.V.
- AFFIMED N.V. - Overview
- AFFIMED N.V. - Product / Service
- AFFIMED N.V. - Key offerings
- SWOT

16.6 Akeso Inc.
- Akeso Inc. - Overview
- Akeso Inc. - Product / Service
- Akeso Inc. - Key offerings
- SWOT

16.7 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT

16.8 Aptevo Therapeutics Inc.
- Aptevo Therapeutics Inc. - Overview
- Aptevo Therapeutics Inc. - Product / Service
- Aptevo Therapeutics Inc. - Key offerings
- SWOT

16.9 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT

16.10 Chugai Pharmaceutical Co. Ltd.
- Chugai Pharmaceutical Co. Ltd. - Overview
- Chugai Pharmaceutical Co. Ltd. - Product / Service
- Chugai Pharmaceutical Co. Ltd. - Key news
- Chugai Pharmaceutical Co. Ltd. - Key offerings
- SWOT

16.11 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT

16.12 EPIMAB BIOTHERAPEUTICS INC.
- EPIMAB BIOTHERAPEUTICS INC. - Overview
- EPIMAB BIOTHERAPEUTICS INC. - Product / Service
- EPIMAB BIOTHERAPEUTICS INC. - Key offerings
- SWOT

16.13 F STAR THERAPEUTICS INC.
- F STAR THERAPEUTICS INC. - Overview
- F STAR THERAPEUTICS INC. - Product / Service
- F STAR THERAPEUTICS INC. - Key offerings
- SWOT

16.14 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT

16.15 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT

16.16 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT

16.17 Mereo BioPharma Group Plc
- Mereo BioPharma Group Plc - Overview
- Mereo BioPharma Group Plc - Product / Service
- Mereo BioPharma Group Plc - Key offerings
- SWOT